/
AOBI
$0.00+$0.00 (+9.09%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.7M | $110.2M | $160.5M | $264.6M | $296.2M | $305.9M | $212.7M | $145.1M |
| Cost of revenue | $19.6M | $38.3M | $49.4M | $91.0M | $129.4M | $148.2M | $112.9M | $100.7M |
| Gross profit | $35.1M | $71.9M | $111.1M | $173.6M | $166.8M | $157.8M | $99.8M | $44.4M |
| Gross margin | 64.2% | 65.2% | 69.2% | 65.6% | 56.3% | 51.6% | 46.9% | 30.6% |
| R&D | $537.8K | $742.7K | $0 | $13.8M | $7.9M | $15.4M | $12.7M | $6.2M |
| Operating income | $18.3M | $36.4M | $52.2M | $63.5M | $58.8M | $30.4M | −$3.5M | −$55.0M |
| EBITDA | $20.5M | $39.6M | $57.0M | $72.2M | $72.7M | $42.0M | −$48.8M | −$39.6M |
| Net income | $13.4M | $29.2M | $43.3M | $47.1M | $41.4M | $14.1M | −$68.5M | −$59.7M |
| Net margin | 24.5% | 26.5% | 27.0% | 17.8% | 14.0% | 4.6% | -32.2% | -41.2% |
| EPS (diluted) | 310.62 | 460.92 | 611.22 | 611.22 | 1062.12 | 185.37 | -901.80 | -781.24 |
Annual figures · source: Financial Modeling Prep
Peer comparison
AMERICAN ORINTL BIOEN
AMERICAN ORINTL BIOEN
Held by traders on TradeandTell
No one on the platform currently holds AOBI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AOBI as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2014-04-03 | 1-for-501reverse |
Recent trades on TradeandTell
No one on the platform has traded AOBI yet.